NeuroSense Therapeutics Ltd. (NRSNW) Net income 2021–2025
NeuroSense Therapeutics Ltd. (NRSNW) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$11.1MFY2025 · since FY2021: -$3.2M → -$11.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$11.1M | -9.0% |
| FY2024 | -$10.2M | -1.0% |
| FY2023 | -$10.1M | +3.7% |
| FY2022 | -$10.5M | -225.8% |
| FY2021 | -$3.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More NRSNW financial trends
NRSNW RevenueNRSNW Net marginNRSNW Gross profitNRSNW Gross marginNRSNW Operating incomeNRSNW Operating marginNRSNW Operating cash flowNRSNW Free cash flowNRSNW Capital expendituresNRSNW Return on equityNRSNW Stock buybacksNRSNW Dividends paidNRSNW Total assetsNRSNW Total liabilitiesNRSNW Shareholders’ equityNRSNW overview →